Hepatobiliary cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben-Josef, P. Mark Bloomston, Jean F. Botha, Bryan M. Clary, Anne Covey, Steven A. Curley, Michael I. D'Angelica, Rene Davila, William D. Ensminger, John F. Gibbs, Daniel Laheru, Mokenge P. Malafa, Jorge Marrero, Steven G. Meranze, Sean J. Mulvihill, James O. Park, James A. Posey, Jasgit SachdevRiad Salem, Elin R. Sigurdson, Constantinos Sofocleous, Jean Nicholas Vauthey, Alan P. Venook, Laura Williams Goff, Yun Yen, Andrew X. Zhu

Research output: Contribution to journalReview articlepeer-review

40 Citations (Scopus)


Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

Original languageEnglish
Pages (from-to)350-351+366-390
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number4
Publication statusPublished - Apr 2009
Externally publishedYes


  • Biologic therapy
  • Chemoembolization
  • Chemotherapy
  • Cholangiocarcinomas
  • Cirrhosis
  • Gallbladder cancer
  • Hepatitis
  • Hepatocellular carcinoma
  • NCCN Clinical practice Guidelines
  • Surgical resection
  • Transplantation
  • Tumor ablation

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Hepatobiliary cancers'. Together they form a unique fingerprint.

Cite this